Foto del docente

Camilla Evangelisti

Professoressa associata

Dipartimento di Scienze Biomediche e Neuromotorie

Settore scientifico disciplinare: BIO/16 ANATOMIA UMANA

Pubblicazioni

J.A. McCubrey; L.S. Steelman; W.H. Chappell; S.L. Abrams; R.A. Franklin; G. Montalto; M. Cervello; M. Libra; S. Candido; G. Malaponte; M.C. Mazzarino; P. Fagone; F. Nicoletti; J. Bäsecke; S. Mijatovic; D.Maksimovic-Ivanic; M. Milella; A. Tafuri; F. Chiarini; C. Evangelisti; L. Cocco; A.M. Martelli., Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance., «ONCOTARGET», 2012, 3, pp. 1068 - 1111 [articolo]

J. A. McCubrey; L.S. Steelman; S.L. Abrams; N. Misaghian; W.H. Chappell1; J. Bäsecke; F. Nicoletti; M. Libra; G. Ligresti; F. Stivala; D. Maksimovic-Ivanic; S. Mijatovic; G. Montalto; M. Cervello; P. Laidler; A. Bonati; C. Evangelisti; L. Cocco; A.M. Martelli., Targeting the cancer initiating cell: the ultimate target for cancer therapy., «CURRENT PHARMACEUTICAL DESIGN», 2012, 18, pp. 1784 - 1795 [articolo]

Alberto M Martelli;Francesca Chiarini;Camilla Evangelisti;Andrea Ognibene;Daniela Bressanin;Anna Maria Billi;Lucia Manzoli;Alessandra Cappellini;James A McCubrey, Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies, «EXPERT OPINION ON THERAPEUTIC TARGETS», 2012, 16, pp. 729 - 742 [articolo]

A.M. Martelli; G. Tabellini; D. Bressanin; A. Ognibene; K. Goto; L. Cocco; C. Evangelisti., The emerging multiple roles of nuclear Akt., «BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH», 2012, 1823, pp. 2168 - 2178 [articolo]

A.M. Martelli; F. Chiarini; C. Evangelisti; A. Cappellini; F. Buontempo; D. Bressanin; M. Fini; J.A. McCubrey, Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment., «ONCOTARGET», 2012, 3, pp. 371 - 394 [articolo]

A.M. Martelli; C. Evangelisti; F. Chiarini; C. Grimaldi; L. Manzoli; J.A. McCubrey., Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia., «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2009, 18, pp. 1333 - 1349 [articolo]

Martelli AM; Evangelisti C; Billi AM; Manzoli L; Papa V; Cocco L, Intranuclear 3'-phosphoinositide metabolism and apoptosis protection in PC12 cells, «ACTA BIO-MEDICA DE L'ATENEO PARMENSE», 2007, 78, pp. 113 - 119 [articolo]

Tazzari P.L.; Cappellini A.; Ricci F.; Evangelisti C.; Papa V.;Grafone T.; Martinelli G.; Conte R.; Cocco L.; McCubrey J.A.; Martelli A.M., Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts., «LEUKEMIA», 2007, 21, pp. 427 - 438 [articolo]

Evangelisti C; Bortul R; Fala F; Tabellini G; Goto K; Martelli AM, Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks, «HISTOLOGY AND HISTOPATHOLOGY», 2007, 22, pp. 573 - 579 [articolo]

Evangelisti C; Tazzari PL; Riccio M; Fiume R; Hozumi Y; Fala F; Goto K; Manzoli L; Cocco L; Martelli AM, Nuclear diacylglycerol kinase-{zeta} is a negative regulator of cell cycle progression in C2C12 mouse myoblasts, «THE FASEB JOURNAL», 2007, 21, pp. 3297 - 3307 [articolo]

McCubrey JA; Steelman LS; Chappell WH; Abrams SL; Wong EW; Chang F; Lehmann B; Terrian DM; Milella M; Tafuri A; Stivala F; Libra M; Basecke J; Evangelisti C; Martelli AM; Franklin RA, Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance, «BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH», 2007, 1773, pp. 1263 - 1284 [articolo]

Martelli AM; Tazzari PL; Evangelisti C; Chiarini F; Blalock WL; Billi AM; Manzoli L; McCubrey JA; Cocco L, Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside., «CURRENT MEDICINAL CHEMISTRY», 2007, 14, pp. 2009 - 2023 [articolo]

McCubrey J.A.; Steelman L.S.; Franklin R.A.; Abrams S.L.; Chappell W.H.; Wong E.W.; Lehmann B.D.; Terrian D.M.; Basecke J.; Stivala F.; Libra M.; Evangelisti C.; Martelli A.M., Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance, in: Advances in Enzyme Regulation - 47, AMSTERDAM, Elsevier, 2007, pp. 64 - 103 [capitolo di libro]

Tazzari PL; Tabellini G; Bortul R; Papa V; Evangelisti C; Grafone T; Martinelli G; McCubrey JA; Martelli AM, The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion, «LEUKEMIA», 2007, 21, pp. 886 - 896 [articolo]

AM Martelli; G Tabellini; R Bortul; M Nyåkern; PL Tazzari; C Evangelisti; L Cocco, The Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway as a Therapeutic Target for the Treatment of Human Acute Myeloid Leukemia (AML), «CURRENT SIGNAL TRANSDUCTION THERAPY», 2007, 2, pp. 246 - 256 [articolo]

Ultimi avvisi

Al momento non sono presenti avvisi.